Business · 24/08/2015

FDA Corrects Notice on Surrogate Endpoints for Kidney Transplantation Clinical Trials

The Food and Drug Administration (FDA) is correcting a notice that was published in the Federal Register on August 3, 2015, regarding a public workshop on surrogate endpoints for clinical trials in kidney transplantation, which was initially missing email and fax contact information and the option for online registration.